• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外调节性T细胞抑制试验。

In vitro Treg suppression assays.

作者信息

Collison Lauren W, Vignali Dario A A

机构信息

Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.

出版信息

Methods Mol Biol. 2011;707:21-37. doi: 10.1007/978-1-61737-979-6_2.

DOI:10.1007/978-1-61737-979-6_2
PMID:21287326
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3043080/
Abstract

Determining the activity of a regulatory T-cell population in vitro is often the first step in analyzing its function. To obtain reliable and reproducible results, it is critical to follow the protocol that is most applicable to your experimental question. We have outlined below a basic in vitro suppression assay as well as a variety of alternative/additional protocols that can be utilized alone or in combination as desired.

摘要

在体外确定调节性T细胞群体的活性通常是分析其功能的第一步。为了获得可靠且可重复的结果,遵循最适用于您实验问题的方案至关重要。我们在下面概述了一种基本的体外抑制试验以及多种可单独或根据需要组合使用的替代/附加方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d24/3043080/5cb57060c267/nihms-272907-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d24/3043080/400d6058d617/nihms-272907-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d24/3043080/b4cbe0f6010d/nihms-272907-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d24/3043080/91c9b0a0901b/nihms-272907-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d24/3043080/0dcdf162af3a/nihms-272907-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d24/3043080/8e92462b9599/nihms-272907-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d24/3043080/5cb57060c267/nihms-272907-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d24/3043080/400d6058d617/nihms-272907-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d24/3043080/b4cbe0f6010d/nihms-272907-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d24/3043080/91c9b0a0901b/nihms-272907-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d24/3043080/0dcdf162af3a/nihms-272907-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d24/3043080/8e92462b9599/nihms-272907-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d24/3043080/5cb57060c267/nihms-272907-f0006.jpg

相似文献

1
In vitro Treg suppression assays.体外调节性T细胞抑制试验。
Methods Mol Biol. 2011;707:21-37. doi: 10.1007/978-1-61737-979-6_2.
2
In vitro suppression assay for functional assessment of human regulatory T cells.用于人类调节性T细胞功能评估的体外抑制试验
Methods Mol Biol. 2013;979:199-212. doi: 10.1007/978-1-62703-290-2_16.
3
Development of assay platforms for in vitro screening of Treg modulating potential of pharmacological compounds.用于体外筛选药物化合物调节调节性T细胞(Treg)潜能的检测平台的开发。
Immunopharmacol Immunotoxicol. 2015 Feb;37(1):63-71. doi: 10.3109/08923973.2014.977449. Epub 2014 Nov 4.
4
Dendritic Cells Coordinate the Development and Homeostasis of Organ-Specific Regulatory T Cells.树突状细胞协调器官特异性调节性T细胞的发育与稳态。
Immunity. 2016 Apr 19;44(4):847-59. doi: 10.1016/j.immuni.2016.01.025. Epub 2016 Mar 29.
5
Inhibition of activation induced CD154 on CD4+ CD25- cells: a valid surrogate for human Treg suppressor function.抑制激活诱导的 CD154 在 CD4+ CD25- 细胞上的表达:人类 Treg 抑制功能的有效替代指标。
Immunol Cell Biol. 2012 Sep;90(8):812-21. doi: 10.1038/icb.2012.18. Epub 2012 Jun 12.
6
Assessment of suppressive capacity by human regulatory T cells using a reproducible, bi-directional CFSE-based in vitro assay.
Methods Mol Biol. 2011;707:233-41. doi: 10.1007/978-1-61737-979-6_15.
7
Monitoring the frequency and function of regulatory T cells and summary of the approaches currently used to inhibit regulatory T cells in cancer patients.
Methods Mol Biol. 2014;1139:201-21. doi: 10.1007/978-1-4939-0345-0_18.
8
Regulatory T Cell Development.调节性 T 细胞的发育。
Annu Rev Immunol. 2020 Apr 26;38:421-453. doi: 10.1146/annurev-immunol-100219-020937. Epub 2020 Jan 28.
9
Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation.Foxp3+天然调节性T细胞在体外优先在树突状细胞上形成聚集体,并积极抑制其成熟。
Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):10113-8. doi: 10.1073/pnas.0711106105. Epub 2008 Jul 17.
10
Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen.特定的调节性T细胞在用同源抗原激活后,对实验性自身免疫性脑脊髓炎具有广泛的抑制功能。
J Immunol. 2005 Jun 1;174(11):6772-80. doi: 10.4049/jimmunol.174.11.6772.

引用本文的文献

1
Susceptibility to and severity of tuberculosis infection in mice depends upon MHC-II-determined level of activation-inhibition balance in CD4 T-cells.小鼠对结核感染的易感性和严重程度取决于主要组织相容性复合体II类分子(MHC-II)所决定的CD4 T细胞激活-抑制平衡水平。
Front Immunol. 2025 Aug 12;16:1608769. doi: 10.3389/fimmu.2025.1608769. eCollection 2025.
2
Navigating the manufacturing, testing and regulatory complexities of regulatory T cells for adoptive cell therapy.应对用于过继性细胞治疗的调节性T细胞在制造、测试及监管方面的复杂性。
Front Immunol. 2025 Jul 16;16:1626085. doi: 10.3389/fimmu.2025.1626085. eCollection 2025.
3

本文引用的文献

1
Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35- and IL-10-dependent manner.调节性T细胞的抑制作用通过细胞接触、依赖白细胞介素-35和白细胞介素-10的方式,由靶T细胞增强。
J Immunol. 2009 May 15;182(10):6121-8. doi: 10.4049/jimmunol.0803646.
2
Cutting edge: regulatory T cells do not require stimulation through their TCR to suppress.前沿:调节性T细胞抑制作用无需通过其TCR进行刺激。
J Immunol. 2009 May 1;182(9):5188-92. doi: 10.4049/jimmunol.0803123.
3
How regulatory T cells work.调节性T细胞的工作方式。
Neuropilin-2 functions as a coinhibitory receptor to regulate antigen-induced inflammation and allograft rejection.
神经纤毛蛋白-2作为一种共抑制受体发挥作用,以调节抗原诱导的炎症和同种异体移植排斥反应。
J Clin Invest. 2025 Jul 1;135(13). doi: 10.1172/JCI172218.
4
The Role of Tregs in the Tumor Microenvironment.调节性T细胞在肿瘤微环境中的作用。
Biomedicines. 2025 May 11;13(5):1173. doi: 10.3390/biomedicines13051173.
5
Anti-vascular endothelial growth factor treatment potentiates immune checkpoint blockade through a BAFF- and IL-12-dependent reprogramming of the TME.抗血管内皮生长因子治疗通过对肿瘤微环境进行BAFF和IL-12依赖性重编程来增强免疫检查点阻断作用。
Immunity. 2025 Apr 8;58(4):926-945.e10. doi: 10.1016/j.immuni.2025.02.017. Epub 2025 Mar 14.
6
High-affinity chimeric antigen receptor signaling induces an inflammatory program in human regulatory T cells.高亲和力嵌合抗原受体信号传导在人类调节性T细胞中诱导炎症程序。
Mol Ther Methods Clin Dev. 2024 Nov 18;32(4):101385. doi: 10.1016/j.omtm.2024.101385. eCollection 2024 Dec 12.
7
Vimentin modulates regulatory T cell receptor-ligand interactions at distal pole complex, leading to dysregulated host response to viral pneumonia.波形蛋白调节远极复合物处的调节性T细胞受体-配体相互作用,导致宿主对病毒性肺炎的反应失调。
Cell Rep. 2024 Dec 24;43(12):115056. doi: 10.1016/j.celrep.2024.115056. Epub 2024 Dec 7.
8
Galectin-1 is associated with hematopoietic cell engraftment in murine MHC-mismatched allotransplantation.半乳糖凝集素-1 与小鼠 MHC 错配同种异体移植中造血细胞植入有关。
Front Immunol. 2024 Sep 16;15:1411392. doi: 10.3389/fimmu.2024.1411392. eCollection 2024.
9
ST2 + T-Regulatory Cells in Renal Inflammation and Fibrosis after Ischemic Kidney Injury.缺血性肾损伤后肾脏炎症和纤维化中的ST2 + 调节性T细胞
J Am Soc Nephrol. 2025 Jan 1;36(1):73-86. doi: 10.1681/ASN.0000000000000471. Epub 2024 Aug 26.
10
Mitigation of checkpoint inhibitor-induced autoimmune hemolytic anemia through modulation of purinergic signaling.通过嘌呤能信号转导缓解检查点抑制剂诱导的自身免疫性溶血性贫血。
Blood. 2024 Oct 10;144(15):1581-1594. doi: 10.1182/blood.2024024230.
Nat Rev Immunol. 2008 Jul;8(7):523-32. doi: 10.1038/nri2343.
4
Role of thymic- and graft-dependent mechanisms in tolerance induction to rat kidney transplant by donor PBMC infusion.胸腺依赖性和移植物依赖性机制在通过供体外周血单个核细胞输注诱导大鼠肾移植耐受中的作用。
Kidney Int. 2007 Jun;71(11):1132-41. doi: 10.1038/sj.ki.5002202. Epub 2007 Mar 21.
5
Efficient and reproducible large-scale isolation of human CD4+ CD25+ regulatory T cells with potent suppressor activity.
J Immunol Methods. 2006 Aug 31;315(1-2):27-36. doi: 10.1016/j.jim.2006.06.014. Epub 2006 Jul 21.
6
Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells.Toll样受体2信号传导调节CD4+CD25+调节性T细胞的功能。
Proc Natl Acad Sci U S A. 2006 May 2;103(18):7048-53. doi: 10.1073/pnas.0601554103. Epub 2006 Apr 21.
7
Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system.自身免疫性脑脊髓炎的自然恢复与保护:中枢神经系统内CD4 + CD25 +调节性细胞的作用
J Immunol. 2005 Sep 1;175(5):3025-32. doi: 10.4049/jimmunol.175.5.3025.
8
Suppressor T cells in human diseases.人类疾病中的抑制性T细胞。
J Exp Med. 2004 Aug 2;200(3):273-6. doi: 10.1084/jem.20040812. Epub 2004 Jul 26.
9
Human CD4+CD25+ regulatory T cells.人CD4+CD25+调节性T细胞。
Semin Immunol. 2004 Apr;16(2):89-98. doi: 10.1016/j.smim.2003.12.005.
10
CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity.CD4+CD25+调节性T细胞控制着硕大利什曼原虫的持续存在和免疫反应。
Nature. 2002 Dec 5;420(6915):502-7. doi: 10.1038/nature01152.